Advertisement
Choose date and time: ×
Yesterday
In the last 7 days
In the last month
HHS Allocates Regeneron Therapeutic to Treat Patients With Mild to Moderate COVID-19 U.S. Department of Health and Human Services (Press Release)14:41 23-Nov-20
FDA OKs Emergency Use of Regeneron’s COVID-19 Antibody “Cocktail” Genetic Engineering and Biotechnology News08:36 23-Nov-20
Coronavirus: FDA authorises Regeneron treatment The Brussels Times10:28 22-Nov-20
3 Best Pharma Stocks to Buy Right Now The Motley Fool07:07 22-Nov-20
FDA allows emergency use of antibody drug Trump received Pittsburgh Tribune-Review23:31 21-Nov-20
Regeneron Announces Investor Conference Presentations PR Newswire (Press Release)16:25 13-Nov-20
FDA Authorizes Eli Lilly’s Covid Antibody Drug Barron's Online15:04 10-Nov-20
Regeneron Delivers Strong Growth Barron's Online09:32 5-Nov-20
Best Biotech ETFs for Q1 2021 Investopedia12:29 4-Nov-20
IDMC recommends modifications to Regeneron COVID-19 antibody trial European Pharmaceutical Review06:59 4-Nov-20
Regeneron named top biopharma company to work for European Pharmaceutical Review09:37 2-Nov-20
view more headlines
2 Dec 13:18

Publication filters

Headline Density

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Sorry, no headlines or news topics were found. Please try different keywords.